Nasdaq

ONWARD Medical Builds Commercial Momentum for the ARC-EX System and Reinforces its Brain-Computer Interface Leadership in Q1 2025

"Our Q1 achievements reflect ONWARD’s successful transition to a commercial organization that delivers breakthrough therapies to people with spinal cord injuries," said Dave Marver, Chief Executive ...
Seeking Alpha

ONWARD Medical Files 510(k) with US FDA for ARC-EX System Home Use and Submits CE Mark Application

FDA 510(k) application submitted to allow marketing of the ARC-EX ® System for home use in the United States CE Mark application filed with notified body to enable commercialization of the ARC-EX ...
Nasdaq

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use

EINDHOVEN, the Netherlands, Nov. 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, ...
KHON2

ONWARD's FDA-Authorized ARC-EX System Restores Hand Strength and Sensation in Spinal Cord Injury Patients

ONWARD's ARC-EX System uses spinal cord stimulation to boost strength and mobility, offering new hope for Veterans and those with spinal cord injuries. We’re excited to see the ARC-EX System receive ...
WDAF-TV

ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025

EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, ...
FOX40 News

ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy

Framework to determine stimulation parameters for ONWARD ARC-EX Therapy are published in the journal Neuromodulation: Technology at the Neural Interface Peer-reviewed publication is based on results ...
ksn.com

ONWARD Medical Announces Publication of One-Year Study Showing Benefit of Sustained Access to ARC-EX Therapy

EINDHOVEN, the Netherlands, Feb. 25, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore ...
Fox 5 San Diego

ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, The Netherlands, Sept. 02, 2025 (GLOBE NEWSWIRE) -- ...
STAT

FDA OKs novel device for non-invasive treatment of spinal cord injuries

Rose covers disability and mental health, and she helps write STAT’s daily Morning Rounds newsletter. Confidential tips can be sent to Rose on Signal at rosebroderick.11. Spinal cord injuries ...
Time

Therapy for Spinal Cord Injuries

Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...
Seeking Alpha

ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use

US FDA clearance now allows use of the ARC-EX ® System both in clinics and homes ARC-EX is the first and only FDA-cleared technology demonstrated to improve hand strength and sensation in people with ...